“…Examinations of gastric emptying, patency of anastomoses, enterogastric reflux, hepatic and thyroid diseases, osteoporosis and metastasis, frequently are carried after bariatric surgery (Kitabaiashi et al, 2002;Fonseca et al, 2000;Badiali et al, 2001;Obradovic et al, 2000). Several works have studied the relationship between chemotherapy, phytotherapy and other drugs with the biodistribution of sodium pertechnetate (Braga et al, 2000;Oliveira et al, 2002;Gomes et al, 1998;Ripoll-Hamer et al, 1995;Simões et al, 1997;Feliciano et al, 2002, Abreu et al, 2006., Santos et al, 1995. With regard to potential consequences of bariatric surgery in the biodistribution of radiopharmaceuticals, little or no study was published until now.…”